Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data

Clinical trial NCT07287904 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07287904
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Lung Cancer (NSCLC)EGFR Activating Mutation Adenocarcinoma Lung Postoperative Adjuvant Therapy

Start date: 2025-12-25
Primary completion: 2027-07-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.